These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 19263187)

  • 1. Rituximab in cryoglobulinemic peripheral neuropathy.
    Cavallo R; Roccatello D; Menegatti E; Naretto C; Napoli F; Baldovino S
    J Neurol; 2009 Jul; 256(7):1076-82. PubMed ID: 19263187
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rituximab as a therapeutic tool in severe mixed cryoglobulinemia.
    Roccatello D; Baldovino S; Rossi D; Giachino O; Mansouri M; Naretto C; Di Simone D; Francica S; Cavallo R; Alpa M; Napoli F; Sena LM
    Clin Rev Allergy Immunol; 2008 Feb; 34(1):111-7. PubMed ID: 18270864
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment for cryoglobulinemic and non-cryoglobulinemic peripheral neuropathy associated with hepatitis C virus infection.
    Benstead TJ; Chalk CH; Parks NE
    Cochrane Database Syst Rev; 2014 Dec; 2014(12):CD010404. PubMed ID: 25525951
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment with rituximab in patients with mixed cryoglobulinemia syndrome: results of multicenter cohort study and review of the literature.
    Ferri C; Cacoub P; Mazzaro C; Roccatello D; Scaini P; Sebastiani M; Tavoni A; Zignego AL; De Vita S
    Autoimmun Rev; 2011 Nov; 11(1):48-55. PubMed ID: 21821153
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rituximab therapy in monoclonal IgM-related neuropathies.
    Kilidireas C; Anagnostopoulos A; Karandreas N; Mouselimi L; Dimopoulos MA
    Leuk Lymphoma; 2006 May; 47(5):859-64. PubMed ID: 16753870
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peripheral neuropathy in mixed cryoglobulinemia: clinical and electrophysiologic investigations.
    Ferri C; La Civita L; Cirafisi C; Siciliano G; Longombardo G; Bombardieri S; Rossi B
    J Rheumatol; 1992 Jun; 19(6):889-95. PubMed ID: 1328632
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term effects of anti-CD20 monoclonal antibody treatment of cryoglobulinaemic glomerulonephritis.
    Roccatello D; Baldovino S; Rossi D; Mansouri M; Naretto C; Gennaro M; Cavallo R; Alpa M; Costanzo P; Giachino O; Mazzucco G; Sena LM
    Nephrol Dial Transplant; 2004 Dec; 19(12):3054-61. PubMed ID: 15494358
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Response to rituximab in patients with type II cryoglobulinemia.
    Bryce AH; Dispenzieri A; Kyle RA; Lacy MQ; Rajkumar SV; Inwards DJ; Yasenchak CA; Kumar SK; Gertz MA
    Clin Lymphoma Myeloma; 2006 Sep; 7(2):140-4. PubMed ID: 17026826
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of cryoglobulinemia associated peripheral neuropathy with rituximab.
    Cai FZ; Ahern M; Smith M
    J Rheumatol; 2006 Jun; 33(6):1197-8. PubMed ID: 16755669
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monoclonal antibody treatment of mixed cryoglobulinemia resistant to interferon alpha with an anti-CD20.
    Sansonno D; De Re V; Lauletta G; Tucci FA; Boiocchi M; Dammacco F
    Blood; 2003 May; 101(10):3818-26. PubMed ID: 12506023
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pegylated interferon-alpha, ribavirin, and rituximab combined therapy of hepatitis C virus-related mixed cryoglobulinemia: a long-term study.
    Dammacco F; Tucci FA; Lauletta G; Gatti P; De Re V; Conteduca V; Sansonno S; Russi S; Mariggiò MA; Chironna M; Sansonno D
    Blood; 2010 Jul; 116(3):343-53. PubMed ID: 20308602
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of rituximab in type II mixed cryoglobulinemia.
    Zaja F; De Vita S; Mazzaro C; Sacco S; Damiani D; De Marchi G; Michelutti A; Baccarani M; Fanin R; Ferraccioli G
    Blood; 2003 May; 101(10):3827-34. PubMed ID: 12560225
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improved (4 Plus 2) Rituximab Protocol for Severe Cases of Mixed Cryoglobulinemia: A 6-Year Observational Study.
    Roccatello D; Sciascia S; Baldovino S; Rossi D; Alpa M; Naretto C; Di Simone D; Menegatti E
    Am J Nephrol; 2016; 43(4):251-60. PubMed ID: 27161362
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rituximab plus Peg-interferon-alpha/ribavirin compared with Peg-interferon-alpha/ribavirin in hepatitis C-related mixed cryoglobulinemia.
    Saadoun D; Resche Rigon M; Sene D; Terrier B; Karras A; Perard L; Schoindre Y; Coppéré B; Blanc F; Musset L; Piette JC; Rosenzwajg M; Cacoub P
    Blood; 2010 Jul; 116(3):326-34; quiz 504-5. PubMed ID: 20439619
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A phase II, single-arm multicenter study of low-dose rituximab for refractory mixed cryoglobulinemia secondary to hepatitis C virus infection.
    Visentini M; Ludovisi S; Petrarca A; Pulvirenti F; Zaramella M; Monti M; Conti V; Ranieri J; Colantuono S; Fognani E; Piluso A; Tinelli C; Zignego AL; Mondelli MU; Fiorilli M; Casato M
    Autoimmun Rev; 2011 Sep; 10(11):714-9. PubMed ID: 21570494
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Cryoglobulinemia and hepatitis c: worsening of peripheral neuropathy after interferon alpha treatment].
    Lidove O; Cacoub P; Hausfater P; Wechsler B; Frances C; Leger JM; Piette JC
    Gastroenterol Clin Biol; 1999 Mar; 23(3):403-6. PubMed ID: 10384347
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cold agglutinin disease and cryoglobulinemia.
    Gertz MA
    Clin Lymphoma; 2005 Mar; 5(4):290-3. PubMed ID: 15794868
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term efficacy of rituximab in hepatitis C virus-associated cryoglobulinemia.
    da Silva Fucuta Pereira P; Lemos LB; de Oliveira Uehara SN; de Souza E Silva IS; Silva AE; Ferraz ML
    Rheumatol Int; 2010 Sep; 30(11):1515-8. PubMed ID: 19705122
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety and efficacy of rituximab in patients with hepatitis C virus-related mixed cryoglobulinemia and severe liver disease.
    Petrarca A; Rigacci L; Caini P; Colagrande S; Romagnoli P; Vizzutti F; Arena U; Giannini C; Monti M; Montalto P; Matucci-Cerinic M; Bosi A; Laffi G; Zignego AL
    Blood; 2010 Jul; 116(3):335-42. PubMed ID: 20308604
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cryoglobulinaemia type III with severe neuropathy and immune complex glomerulonephritis: remission after plasmapheresis and rituximab.
    Braun A; Neumann T; Oelzner P; Hein G; Gröne HJ; Ziemer M; Wolf G
    Rheumatol Int; 2008 Mar; 28(5):503-6. PubMed ID: 17924113
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.